Home » Topics » BioWorld Science

BioWorld Science
RSS

Merck & Co. identifies Nav1.7 channel blockers

June 11, 2018

Prolia approved in Europe for patients with glucocorticoid-induced osteoporosis

June 11, 2018

Bristol-Myers Squibb divulges integrin alphaV antagonists

June 11, 2018

Dana-Farber Cancer Institute patents new PROTAC compounds for cancer

June 11, 2018

Modest data for PI3K inhibitor taselisib in breast cancer

June 11, 2018

Bayer closes its acquisition of Monsanto

June 11, 2018

NOSO-502: a new antibacterial drug candidate active against carbapenem-resistant Enterobacteriaceae

June 11, 2018

FDA approves Rituxan for moderate to severe pemphigus vulgaris

June 11, 2018

FDA approves IND application for clinical study of RK-01

June 11, 2018

Updated interim data from phase I/II study of lumasiran for primary hyperoxaluria type 1

June 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...